CoChat

Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

Rokkas, Theodore, Gisbert, Javier P., Malfertheiner, Peter, Niv, Yaron, Gasbarrini, Antonio, Leja, Marcis, Megraud, Francis, O’Morain, Colm, Graham, David Y. · 2021 · Gastroenterology
Cited by 185

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND & AIMS A number of double, triple and quadruple therapies have been proposed as first line H. pylori infection empiric treatments. However, knowledge of their worldwide and regional comparative efficacy is lacking. We examined the comparative effectiveness of all empirically used first line regimens tested against standard triple treatment, using a network meta-analysis (NWM) of published RCTs. METHODS Data extracted from eligible RCTs were entered into a Bayesian NWM to investigate the comparative efficacy of H. pylori infection empiric first line regimens and to explore their effectiveness rank order. The ranking probability for each regimen, was evaluated by means of SUCRA (surfaces under cumulative ranking) values. RESULTS Sixty-eight eligible RCTs were included, giving a total of 92 paired comparisons with 22,975 patients, randomized to 8 first line regimens. The overall results showed that only vonoprazan triple therapy and reverse hybrid therapy achieved cure rates of more than 90%. Levofloxacin triple therapy performed best in Western countries (eradication rate 88.5%). The comparative effectiveness ranking showed that vonoprazan triple therapy had the best results, whereas standard triple therapy was the least efficacious regimen [SUCRA 92.4% vs 4.7% respectively, ORs (95% CrI 3.80(1.62-8.94)]. CONCLUSIONS For first line empiric H. pylori infection treatment, vonoprazan triple therapy and reverse hybrid therapy achieved high eradication rates of more than 90%. Levofloxacin triple therapy achieved the highest eradication rates in Western countries. Standard triple therapy was the least efficacious regimen in this NWM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2021.04.012

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 185

Metadata

Authors
Rokkas, T., Gisbert, J. P., Malfertheiner, P., Niv, Y., Gasbarrini, A., Leja, M., Megraud, F., O’Morain, C., & Graham, D. Y.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2021-08
Volume
161
Issue
2
Pages
495-507.e4
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3149792503
Cited by
185
References
7
FWCI
28.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. https://app.cochat.ai/papers/10.1053/j.gastro.2021.04.012
The paper
Rokkas, T., Gisbert, J. P., Malfertheiner, P., Niv, Y., Gasbarrini, A., Leja, M., Megraud, F., O’Morain, C., & Graham, D. Y. (2021). Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology. https://doi.org/10.1053/j.gastro.2021.04.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.